Document is current
Any future updates will be listed below
-
Authors
Udani, Shreya http://orcid.org/0000-0001-8323-8054
Langerman, Justin
Koo, Doyeon http://orcid.org/0000-0001-9877-7237
Baghdasarian, Sevana
Cheng, Brian http://orcid.org/0000-0003-1534-5661
Kang, Simran
Soemardy, Citradewi
de Rutte, Joseph
Plath, Kathrin http://orcid.org/0000-0001-7796-3372
Di Carlo, Dino http://orcid.org/0000-0003-3942-4284
-
Funding
Funding for this research was provided by:
U.S. Department of Health & Human Services | NIH | National Institute of Diabetes and Digestive and Kidney Diseases (R21DK128730, R21DK128730, R21DK128730)
Broad Stem Cell Research Center (BSCRC) and California NanoSystems Institute (CNSI) Stem Cell Nano-Medicine Initiative Planning Award
U.S. Department of Health & Human Services | NIH | National Institute of General Medical Sciences (P01GM099134, P01GM099134)
U.S. Department of Health & Human Services | NIH | National Institute of General Medical Sciences
- License Information
-
More Information
Article History
Received: 3 April 2023
Accepted: 31 October 2023
First Online: 11 December 2023
Competing interests
: S.U., J.L., D.K., J.d.R., K.P. and D.D.C. are inventors on a patent application assigned to the University of California. J.d.R. is an employee of Partillion Bioscience, which is commercializing nanovial technology. J.d.R., D.D.C. and the University of California have financial interests in Partillion Bioscience. The other authors declare no competing interests.
